Literature DB >> 3459341

Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.

U Ganzinger, A Stutz, G Petranyi, A Stephen.   

Abstract

A new class of synthetic antifungal agents, characterized by an allylamine function as the essential structural feature, is reviewed. Two members of this class, identified by the generic name Naftifine and the code number SF 86-327 respectively, which were selected for further development from among several hundred analogous, are described in greater detail. As a class, the allylamines are highly active against dermatophytes and moulds, and moderately active against yeasts. Naftifine has been developed as an agent for the topical treatment of dermatomycoses, while SF 86-327 is under development in both topical and oral formulations, being the first orally applicable antifungal agent with a primarily fungicidal mode of action.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3459341

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  5 in total

Review 1.  Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.

Authors:  J P Monk; R N Brogden
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 2.  In vitro and in vivo evaluation of antifungal agents.

Authors:  A Espinel-Ingroff; S Shadomy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

3.  Antipyrine metabolism is not affected by terbinafine, a new antifungal agent.

Authors:  R Seyffer; M Eichelbaum; J C Jensen; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Effects of squalene epoxidase inhibitors on Candida albicans.

Authors:  N H Georgopapadakou; A Bertasso
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

5.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.